Key result
VASP-PRI independently predicted major cardiovascular events and discriminated ischemic and bleeding events in high-risk Chinese PCI patients.
Why the study?
Although a therapeutic window of P2Y12 receptor inhibition is associated with ischemic and bleeding events, the therapeutic window for high-risk stratification after PCI was lacking.
Does on-treatment platelet P2Y12 reactivity measured by VASP-PRI discriminate 12-month ischemic and bleeding events to define an optimal therapeutic window in high-risk Chinese patients undergoing PCI?
Observational (n=860)
Yes
Does on-treatment platelet P2Y12 reactivity measured by VASP-PRI discriminate 12-month ischemic and bleeding events to define an optimal therapeutic window in high-risk Chinese patients undergoing PCI?
High-risk Chinese PCI patients exhibit a narrower optimal P2Y12 reactivity therapeutic window (24% < VASP-PRI < 45%) than Western cohorts, supporting ethnicity-specific thresholds to balance ischemic protection and bleeding risk.
Answers are grounded in this paper and cite their sources.
Observational data suggest narrower VASP-PRI window in Chinese PCI patients; leaves open randomized confirmation of ethnicity-specific thresholds.
Background Much evidence has been provided that a therapeutic window of P2Y 12 receptor inhibition exists, which is highly significantly associated with ischemic and bleeding events. The therapeutic window for high-risk stratification after percutaneous coronary intervention (PCI) is lacking. We aimed to investigate the therapeutic window of P2Y 12 receptor inhibition in high-risk Chinese PCI patients. Methods In this observational study, we analyzed 860 high-risk patients who were undergoing PCI. The primary endpoint was the correlation between vasodilator-stimulated phosphoprotein platelet reactivity index (VASP-PRI) values with bleeding and ischemic components in high-risk patients. The secondary endpoint was a composite of cardiovascular death, myocardial infarction, definite stent thrombosis, urgent revascularization, and stroke at 12 months after the index procedure. Results Among high-risk patients, VASP-PRI could significantly discriminate between PCI patients with and without ischemic events (area under the curve (AUC): 0.77; 95% CI [0.72–0.82]; P < 0.001). A VASP-PRI ≥ 0.45 was the optimal cutoff point to predict ischemic events (sensitivity: 86.6%; specificity: 63.6%). Similarly, VASP-PRI could also significantly discriminate between PCI patients with and without bleeding events ((AUC): 0.77; 95% CI [0.73–0.81]; P < 0.001). A VASP-PRI ≤ 0.24 was the optimal cutoff point to predict bleeding events (sensitivity: 72.1%; specificity: 70.3%). Multivariate analysis showed that VASP-PRI was an independent predictor of the risk of major adverse cardiovascular events (odds ratio: 10.67, 95% CI [3.78–30.08]). Conclusion Our results suggest that high-risk Chinese PCI patients have a narrow therapeutic window. Within this window, high-risk patients are at lower risk for both ischemic and bleeding events. Platelet reactivity may have significant implications for personalized antiplatelet therapy in high-risk patients.
No takes yet. Share an insight, caveat, or question.
Gong et al. (2026) conducted an observational in High-risk patients with ACS or stable CAD undergoing PCI with drug-eluting stent implantation (n=860). On-treatment platelet P2Y12 reactivity assessed by VASP-PRI on dual antiplatelet therapy (aspirin plus clopidogrel or ticagrelor) vs. Normal on-treatment platelet reactivity (NPR: VASP-PRI 0.24 to 0.45) vs high (HPR: >=0.45) or low (LPR: <=0.24) platelet reactivity was evaluated on Correlation and predictive discrimination of VASP-PRI values with ischemic components (cardiovascular death, MI, definite stent thrombosis, urgent revascularization, stroke) and BARC 2, 3, or 5 bleeding events at 12 months, and independent prediction of MACE (OR 10.67 for MACE (AUC 0.77 for ischemic events; AUC 0.77 for bleeding events), 95% CI 3.78-30.08, p=<0.001). VASP-PRI independently predicted major cardiovascular events and discriminated ischemic and bleeding events in high-risk Chinese PCI patients.
Synapse has enriched 10 related papers. Consider them for comparative context: